Editorial


Who can benefit from postoperative radiotherapy following biochemical recurrence after radical prostatectomy?—looking for the “Rosetta Stone” of prostate cancer

Marco Krengli, Letizia Deantonio, Michele Billia, Alessandro Volpe

Abstract

Over the last 10 years, there has been a growing interest to find a personalized and customized treatment approach for prostate cancer patients, aiming to optimize cancer control and improve functional outcomes.

Download Citation